Open Access Open Access  Restricted Access Subscription or Fee Access

Prescription opioid use duration and beliefs about pain and pain medication in primary care patients

Philip Day, PhD, Scott Secrest, MPH, Dawn Davis, MD, Joanne Salas, MPH, Carissa van den Berk-Clark, PhD, MSW, Neelima Kale, PhD, MD, MBA, Catherine Hearing, MPH, F. David Schneider, MD, MSPH, Jeffrey F. Scherrer, PhD, ARCHNet Investigators

Abstract


Background: Patient beliefs about pain and opioids have been reported from qualitative data. To overcome limitations of unstructured assessments and small sample sizes, we determined if pain and pain medication beliefs varied by chronic pain status and opioid analgesic use (OAU) duration in primary care patients.

Methods: Cross-sectional survey data obtained in 2017 and 2018 from 735 patients 18 years of age. The eight-item Barriers Questionnaire (BQ) measured beliefs about pain and pain medication. Patients reported OAU and use of other pain treatments. Multiple linear regression models estimated the association between never OAU, 1-90 day OAU and >90 day OAU and each BQ item.

Results: Overall, respondents were 49.1 (±15.4) years old, 38.7 percent white, 28.4 percent African-American, 23.5 percent Hispanic, and 68.6 percent female. About one-third never used opioids, 41.8 percent had 1-90 day OAU, and 21.6 percent had > 90 day OAU. Multiple linear regression analyses showed that compared to never OAU, > 90 day OAU had lower average agreement that analgesics are addictive (β = 0.50; 95 percent CI: 0.96, 0.03), and 1-90 day OAU (β = 0.53; 95 percent CI: 0.96, 0.10) and > 90 OAU (β = 0.55; 95 percent CI: 1.04, 0.06) had lower average agreement that analgesics make people do or say embarrassing things.

Conclusions: Patients with chronic OAU reported less concern about addiction and opioid-related behavior change. Never users were most likely to agree that opioids are addictive. There continues to be a need to educate patients about opioid risks. Assessing patients' beliefs may identify patients at risk for chronic OAU.


Keywords


chronic pain, opioids, primary care

Full Text:

PDF

References


Centers for Disease Control and Prevention: 2018 annual surveillance report of drug-related risks and outcomes—United States. Surveillance Special Report 2. Centers for Disease Control and Prevention, U.S. Department of Health and Human Services. 2018. Centers for Disease Control and Prevention. Available at https://www.cdc.gov/drugoverdose/pdf/pubs/2018-cdc-drug-surveillancereport.pdf. Accessed July 8, 2019.

Centers for Disease Control and Prevention: Vital signs: Changes in opioid prescribing in the United States, 2006–2015. MMWR. 2017; 66(26): 697-704.

Vargas-Schaffer G, Cogan J: Attitudes toward opioids and risk of misuse/abuse in patients with chronic noncancer pain receiving long-term opioid therapy. Pain Med. 2018; 19(2): 319-327.

Robinson J, Dansie E, Wilson H, et al.: Attitudes and beliefs of working and work-disabled people with chronic pain prescribed long-term opioids. Pain Med. 2015; 16(7): 1311-1324.

Sullivan M, Von Korff M, Banta-Green C, et al.: Problems and concerns of patients receiving chronic opioid therapy for chronic non-cancer pain. Pain. 2010; 149(2): 345-353.

Deyo A, Dworkin SF, Amtmann D, et al.: Report of the NIH task force on research standards for chronic low back pain. J Pain. 2014; 15(6): 569-85.

Cogan J, Ouimette M, Vargas-Schaffer G, et al.: Patient attitudes and beliefs regarding pain medication after cardiac surgery: Barriers to adequate pain management. Pain Manag Nurs. 2014; 15: 574-579.

Gunnarsdottir S, Serlin RC, Ward S: Patient-related barriers to pain management: the Icelandic Barriers Questionnaire II. J Pain Symptom Manage. 2005; 29(3): 273-285.

Gunnarsdottir S, Donovan HS, Serlin RC, et al.: Patient-related barriers to pain management: the Barriers Questionnaire II (BQ-II). Pain. 2002; 99(3): 385-396.

McCracken LM, Hoskins J, Eccleston C: Concerns about medication and medication use in chronic pain. J Pain. 2007; 7: 726-734.

Jamison RN, Anderson KO, Peetersasdourian C, et al.: Survey of opioid use in chronic nonmalignant pain patients. Reg Anesth. 1994; 19: 225-230.

Wright EM, El-Jawahri A, Temel JS, et al.: Patient patterns and perspectives on using opioid regimens for chronic cancer pain. J Pain Symptom Manage. 2019; 57(6): 1062-1070. doi:10.1016/j.jpainsymman.2019.02.02.

Provenzano DA, Kamal KM, Giannetti V: Evaluation of primary care physician chronic pain management practice patterns. Pain Phys. 2018; 21(6): E593-E602.

Wood E, Samet JH, Volkow ND: Physician education in addiction medicine. JAMA. 2013; 310(16): 1673-1674. doi:10.1001/jama.2013.280377.

O’Connor PG, Nyquist JG, McLellan AT: Integrating addiction medicine into graduate medical education in primary care: The time has come. Ann Intern Med. 2011; 154(1): 56-59. doi:10.7326/0003-4819-154-1-201101040-00008.

Desveaux L, Saragosa M, Kithulegoda N, et al.: Family physician perceptions of their role in managing the opioid crisis. Ann Fam Med. 2019; 17(4): 345-351. doi:10.1370/afm.2413.

Davis B, Archambault C, Davis K, et al.: A patient-centered approach to tapering opioids. J Fam Pract. 2019; 68(10): 548-556.

Calpin P, Imran A, Harmon D: A comparison of expectations of physicians and patients with chronic pain for pain clinic visits. Pain Pract. 2017; 17(3): 305-311. doi:10.1111/papr.12428.

Adams LL, Gatchel RJ, Robinson RC, et al.: Development of self-report screening instrument for assessing potential opioid medication misuse in chronic pain patients. J Pain Symptom Manage. 2004; 27(5): 440-459. doi:10.1016/j.jpainsymman.2003.10.009.

Elander J, Said O, Maratos F, et al.: Development and validation off a short-form pain medication attitudes questionnaire. Pain. 2017; 158(3): 400-407. doi:10.1097/j.pain.0000000000000773.

Hero JO, McMurtry C, Benson J, et al.: Discussing opioid risks with patients to reduce misuse and abuse: Evidence from 2 surveys. Ann Fam Med. 2016; 14(6): 575-577.




DOI: https://doi.org/10.5055/jom.2020.0600

Refbacks

  • There are currently no refbacks.